Enhanced effect of connexin 43 on cisplatin-induced cytotoxicity in mesothelioma cells

Hiromi Sato, Hiroki Iwata, Yasuyuki Takano, Ryota Yamada, Hiroko Okuzawa, Yoji Nagashima, Katsunori Yamaura, Koichi Ueno, Tomohiro Yano

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The expression levels of connexin (Cx) proteins, which are gap junction (GJ) components, are often decreased in many cancers, and restoring their levels has been shown to have antitumor effects. Previously, dysfunctional gap junctional intercellular communication (GJIC) has been observed in several malignant mesotheliomas (MMs), and among the many Cx proteins, Cx43 is prominently expressed in nontumorigenic mesothelial tissues. Therefore, we investigated whether Cx43 upregulation has an antitumor effect on an MM cell line (H28 cell), especially with regard to drug resistance. After treatment with the chemotherapeutic agent cisplatin (CDDP), MM cell viability significantly decreased, and apoptosis induction was observed in Cx43-transfected clones. A specific GJIC inhibitor could not abrogate this effect. On the other hand, the Src protein is known to phosphorylate Cx43, which results in GJIC inhibition. This suggests that Src activity might also be regulated by the hyperexpression of Cx43. In fact, the Src protein level was decreased in Cx43-transfected clones. Moreover, Src inhibition reinforced CDDP cytotoxicity in parental H28 cells. These data suggest that Cx43 could improve the resistance to CDDP in a GJIC-independent manner, which may be partly mediated by the suppression of Src activity.

Original languageEnglish
Pages (from-to)466-475
Number of pages10
JournalJournal of Pharmacological Sciences
Volume110
Issue number4
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Connexin 43
Mesothelioma
Cisplatin
Connexins
Clone Cells
Proteins
Drug Resistance
Cell Survival
Up-Regulation
Epithelium
Apoptosis
Cell Line
Malignant Mesothelioma

Keywords

  • Chemotherapy
  • Cisplatin
  • Connexin
  • Drug resistance
  • Mesothelioma

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Enhanced effect of connexin 43 on cisplatin-induced cytotoxicity in mesothelioma cells. / Sato, Hiromi; Iwata, Hiroki; Takano, Yasuyuki; Yamada, Ryota; Okuzawa, Hiroko; Nagashima, Yoji; Yamaura, Katsunori; Ueno, Koichi; Yano, Tomohiro.

In: Journal of Pharmacological Sciences, Vol. 110, No. 4, 2009, p. 466-475.

Research output: Contribution to journalArticle

Sato, Hiromi ; Iwata, Hiroki ; Takano, Yasuyuki ; Yamada, Ryota ; Okuzawa, Hiroko ; Nagashima, Yoji ; Yamaura, Katsunori ; Ueno, Koichi ; Yano, Tomohiro. / Enhanced effect of connexin 43 on cisplatin-induced cytotoxicity in mesothelioma cells. In: Journal of Pharmacological Sciences. 2009 ; Vol. 110, No. 4. pp. 466-475.
@article{64a1686be313401f8b8d6414e0764878,
title = "Enhanced effect of connexin 43 on cisplatin-induced cytotoxicity in mesothelioma cells",
abstract = "The expression levels of connexin (Cx) proteins, which are gap junction (GJ) components, are often decreased in many cancers, and restoring their levels has been shown to have antitumor effects. Previously, dysfunctional gap junctional intercellular communication (GJIC) has been observed in several malignant mesotheliomas (MMs), and among the many Cx proteins, Cx43 is prominently expressed in nontumorigenic mesothelial tissues. Therefore, we investigated whether Cx43 upregulation has an antitumor effect on an MM cell line (H28 cell), especially with regard to drug resistance. After treatment with the chemotherapeutic agent cisplatin (CDDP), MM cell viability significantly decreased, and apoptosis induction was observed in Cx43-transfected clones. A specific GJIC inhibitor could not abrogate this effect. On the other hand, the Src protein is known to phosphorylate Cx43, which results in GJIC inhibition. This suggests that Src activity might also be regulated by the hyperexpression of Cx43. In fact, the Src protein level was decreased in Cx43-transfected clones. Moreover, Src inhibition reinforced CDDP cytotoxicity in parental H28 cells. These data suggest that Cx43 could improve the resistance to CDDP in a GJIC-independent manner, which may be partly mediated by the suppression of Src activity.",
keywords = "Chemotherapy, Cisplatin, Connexin, Drug resistance, Mesothelioma",
author = "Hiromi Sato and Hiroki Iwata and Yasuyuki Takano and Ryota Yamada and Hiroko Okuzawa and Yoji Nagashima and Katsunori Yamaura and Koichi Ueno and Tomohiro Yano",
year = "2009",
doi = "10.1254/jphs.08327FP",
language = "English",
volume = "110",
pages = "466--475",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8613",
publisher = "Japanese Pharmacological Society",
number = "4",

}

TY - JOUR

T1 - Enhanced effect of connexin 43 on cisplatin-induced cytotoxicity in mesothelioma cells

AU - Sato, Hiromi

AU - Iwata, Hiroki

AU - Takano, Yasuyuki

AU - Yamada, Ryota

AU - Okuzawa, Hiroko

AU - Nagashima, Yoji

AU - Yamaura, Katsunori

AU - Ueno, Koichi

AU - Yano, Tomohiro

PY - 2009

Y1 - 2009

N2 - The expression levels of connexin (Cx) proteins, which are gap junction (GJ) components, are often decreased in many cancers, and restoring their levels has been shown to have antitumor effects. Previously, dysfunctional gap junctional intercellular communication (GJIC) has been observed in several malignant mesotheliomas (MMs), and among the many Cx proteins, Cx43 is prominently expressed in nontumorigenic mesothelial tissues. Therefore, we investigated whether Cx43 upregulation has an antitumor effect on an MM cell line (H28 cell), especially with regard to drug resistance. After treatment with the chemotherapeutic agent cisplatin (CDDP), MM cell viability significantly decreased, and apoptosis induction was observed in Cx43-transfected clones. A specific GJIC inhibitor could not abrogate this effect. On the other hand, the Src protein is known to phosphorylate Cx43, which results in GJIC inhibition. This suggests that Src activity might also be regulated by the hyperexpression of Cx43. In fact, the Src protein level was decreased in Cx43-transfected clones. Moreover, Src inhibition reinforced CDDP cytotoxicity in parental H28 cells. These data suggest that Cx43 could improve the resistance to CDDP in a GJIC-independent manner, which may be partly mediated by the suppression of Src activity.

AB - The expression levels of connexin (Cx) proteins, which are gap junction (GJ) components, are often decreased in many cancers, and restoring their levels has been shown to have antitumor effects. Previously, dysfunctional gap junctional intercellular communication (GJIC) has been observed in several malignant mesotheliomas (MMs), and among the many Cx proteins, Cx43 is prominently expressed in nontumorigenic mesothelial tissues. Therefore, we investigated whether Cx43 upregulation has an antitumor effect on an MM cell line (H28 cell), especially with regard to drug resistance. After treatment with the chemotherapeutic agent cisplatin (CDDP), MM cell viability significantly decreased, and apoptosis induction was observed in Cx43-transfected clones. A specific GJIC inhibitor could not abrogate this effect. On the other hand, the Src protein is known to phosphorylate Cx43, which results in GJIC inhibition. This suggests that Src activity might also be regulated by the hyperexpression of Cx43. In fact, the Src protein level was decreased in Cx43-transfected clones. Moreover, Src inhibition reinforced CDDP cytotoxicity in parental H28 cells. These data suggest that Cx43 could improve the resistance to CDDP in a GJIC-independent manner, which may be partly mediated by the suppression of Src activity.

KW - Chemotherapy

KW - Cisplatin

KW - Connexin

KW - Drug resistance

KW - Mesothelioma

UR - http://www.scopus.com/inward/record.url?scp=68849123924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849123924&partnerID=8YFLogxK

U2 - 10.1254/jphs.08327FP

DO - 10.1254/jphs.08327FP

M3 - Article

C2 - 19652456

AN - SCOPUS:68849123924

VL - 110

SP - 466

EP - 475

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8613

IS - 4

ER -